Editorial: The evolving paradigms and treatments for primary biliary cholangitis
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.17779 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, 2024. Written by Raj Vuppalanchi and 1 co-authors. Institution: Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Major MEDLINE topics: Liver Cirrhosis, Biliary, Cholangitis. Cited 3 times so far (Crossref); 9 references.
Abstract (original language)
LINKED CONTENT This article is linked to Mayo et al papers. To view these articles, visit https://doi.org/10.1111/apt.17755 and https://doi.org/10.1111/apt.17798
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Liver Institute Northwest, Elson S. Floyd College of Medicine, Washington State University, Seattle, Washington, USA.
ORCID profiles: Raj Vuppalanchi
Cite
APA
Vuppalanchi, R., & Kowdley, K. V. (2024). Editorial: The evolving paradigms and treatments for primary biliary cholangitis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17779
Vancouver
Vuppalanchi R, Kowdley KV. Editorial: The evolving paradigms and treatments for primary biliary cholangitis. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17779
BibTeX
@article{Vuppalanchi2024,
author = {Vuppalanchi, Raj and Kowdley, Kris V},
title = {Editorial: The evolving paradigms and treatments for primary biliary cholangitis},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.17779}
}
EUVIMED